全球生物防禦市場 2024-2028

預計2023-2028年生物防禦市場價值為71.6134億美元，預測期內複合年成長率為-4.96%。

該報告包括對生物防禦市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由生技藥品日益成長的威脅、生物恐怖主義的威脅日益增加以及公眾對感染疾病影響的認知不斷提高所推動的。

研究指出，市場參與企業之間產品發布和策略聯盟的增加是推動未來幾年生物防禦市場成長的關鍵因素之一。此外，有利的政府舉措、全球化以及需要更好移民的旅行增加導致了市場的巨大需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 全球生物防禦市場 2018-2022
• 2018-2022 年按類型分類的細分市場分析
• 2018-2022 年按應用分類的細分市場分析
• 2018-2022 年區域細分分析
• 2018-2022 年國家細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章市場細分：按類型

• 市場區隔
• 比較：按類型
• 疫苗：2023-2028 年市場規模與預測
• 藥品：2023-2028 年市場規模與預測
• 市場機會：按類型

第7章 市場區隔：依應用

• 市場區隔
• 比較：按應用
• COVID-19（新型冠狀病毒感染疾病）：2023-2028 年市場規模與預測
• 炭疽菌：2023-2028 年市場規模與預測
• 天花：2023-2028 年市場規模與預測
• 肉毒桿菌：2023-2028 年市場規模與預測
• 其他：2023-2028年市場規模與預測
• 市場機會：依應用分類

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 亞洲：2023-2028年市場規模與預測
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 中國：2023-2028年市場規模及預測
• 印度：2023-2028年市場規模與預測
• 英國：2023-2028 年市場規模與預測
• 德國：2023-2028 年市場規模與預測
• 市場機會：依地區狀況

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商情況

• 概述
• 供應商情況
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• Alnylam Pharmaceuticals Inc.
• Appili Therapeutics Inc.
• AstraZeneca PLC
• Bavarian Nordic AS
• Chimerix Inc.
• Dynavax Technologies Corp.
• Elusys Therapeutics Inc.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Johnson and Johnson
• Novavax Inc.
• Sanofi SA
• SIGA Technologies Inc.
• Soligenix Inc.
• Tonix Pharmaceuticals Holding Corp.

第13章附錄

The biodefense market is forecasted to grow by USD -7161.34 million during 2023-2028, accelerating at a CAGR of -4.96% during the forecast period. The report on the biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing threat posed by biological agents, rising threat of bioterrorism, and growing public awareness of impact of infectious diseases.

Technavio's biodefense market is segmented as below:

By Type

• Vaccines
• Drugs

By Application

• COVID 19
• Anthrax
• Smallpox
• Botulism
• Others

By Geographical Landscape

• Asia
• North America
• Europe
• Rest of World (ROW)

This study identifies the rising product launches and strategic alliances among market participants as one of the prime reasons driving the biodefense market growth during the next few years. Also, favorable government initiatives and globalization and increased travel requiring better immuity will lead to sizable demand in the market.

The report on the biodefense market covers the following areas:

• Biodefense market sizing
• Biodefense market forecast
• Biodefense market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alnylam Pharmaceuticals Inc., Appili Therapeutics Inc., AstraZeneca PLC, Bavarian Nordic AS, Chimerix Inc., Dynavax Technologies Corp., Elusys Therapeutics Inc., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Merck and Co. Inc., Neogen Corp., Novavax Inc., Porton Biopharma Ltd., Sanofi SA, Serum Institute of India Pvt. Ltd., SIGA Technologies Inc., Soligenix Inc., Tonix Pharmaceuticals Holding Corp., Zoetis Inc., and Johnson and Johnson. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global biodefense market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Vaccines - Market size and forecast 2023-2028
• 6.4 Drugs - Market size and forecast 2023-2028
• 6.5 Market opportunity by Type

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 COVID 19 - Market size and forecast 2023-2028
• 7.4 Anthrax - Market size and forecast 2023-2028
• 7.5 Smallpox - Market size and forecast 2023-2028
• 7.6 Botulism - Market size and forecast 2023-2028
• 7.7 Others - Market size and forecast 2023-2028
• 7.8 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 Asia - Market size and forecast 2023-2028
• 9.4 North America - Market size and forecast 2023-2028
• 9.5 Europe - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 India - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Germany - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Alnylam Pharmaceuticals Inc.
• 12.4 Appili Therapeutics Inc.
• 12.5 AstraZeneca PLC
• 12.6 Bavarian Nordic AS
• 12.7 Chimerix Inc.
• 12.8 Dynavax Technologies Corp.
• 12.9 Elusys Therapeutics Inc.
• 12.10 Emergent BioSolutions Inc.
• 12.11 GlaxoSmithKline Plc
• 12.12 Johnson and Johnson
• 12.13 Novavax Inc.
• 12.14 Sanofi SA
• 12.15 SIGA Technologies Inc.
• 12.16 Soligenix Inc.
• 12.17 Tonix Pharmaceuticals Holding Corp.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary €" Chart on Market Overview
• Exhibits2: Executive Summary €" Data Table on Market Overview
• Exhibits3: Executive Summary €" Chart on Global Market Characteristics
• Exhibits4: Executive Summary €" Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary €" Chart on Market Segmentation by Type
• Exhibits6: Executive Summary €" Chart on Market Segmentation by Application
• Exhibits7: Executive Summary €" Chart on Incremental Growth
• Exhibits8: Executive Summary €" Data Table on Incremental Growth
• Exhibits9: Executive Summary €" Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size €" Data Table on global biodefense market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size €" Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size €" Application Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size €" Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size €" Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers €" Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers €" Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants €" Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes €" Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry €" Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Drugs - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Application - Market share 2023-2028 (%)
• Exhibits45: Data Table on Application - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on COVID 19 - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on COVID 19 - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on COVID 19 - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on COVID 19 - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Anthrax - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Anthrax - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Anthrax - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Anthrax - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Smallpox - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Smallpox - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Smallpox - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Smallpox - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Botulism - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Botulism - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Botulism - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Botulism - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Application ($ million)
• Exhibits69: Data Table on Market opportunity by Application ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Alnylam Pharmaceuticals Inc. - Overview
• Exhibits120: Alnylam Pharmaceuticals Inc. - Product / Service
• Exhibits121: Alnylam Pharmaceuticals Inc. - Key offerings
• Exhibits122: Appili Therapeutics Inc. - Overview
• Exhibits123: Appili Therapeutics Inc. - Product / Service
• Exhibits124: Appili Therapeutics Inc. - Key offerings
• Exhibits125: AstraZeneca PLC - Overview
• Exhibits126: AstraZeneca PLC - Product / Service
• Exhibits127: AstraZeneca PLC - Key news
• Exhibits128: AstraZeneca PLC - Key offerings
• Exhibits129: Bavarian Nordic AS - Overview
• Exhibits130: Bavarian Nordic AS - Product / Service
• Exhibits131: Bavarian Nordic AS - Key offerings
• Exhibits132: Chimerix Inc. - Overview
• Exhibits133: Chimerix Inc. - Product / Service
• Exhibits134: Chimerix Inc. - Key offerings
• Exhibits135: Dynavax Technologies Corp. - Overview
• Exhibits136: Dynavax Technologies Corp. - Product / Service
• Exhibits137: Dynavax Technologies Corp. - Key offerings
• Exhibits138: Elusys Therapeutics Inc. - Overview
• Exhibits139: Elusys Therapeutics Inc. - Product / Service
• Exhibits140: Elusys Therapeutics Inc. - Key offerings
• Exhibits141: Emergent BioSolutions Inc. - Overview
• Exhibits142: Emergent BioSolutions Inc. - Product / Service
• Exhibits143: Emergent BioSolutions Inc. - Key news
• Exhibits144: Emergent BioSolutions Inc. - Key offerings
• Exhibits145: GlaxoSmithKline Plc - Overview
• Exhibits146: GlaxoSmithKline Plc - Business segments
• Exhibits147: GlaxoSmithKline Plc - Key news
• Exhibits148: GlaxoSmithKline Plc - Key offerings
• Exhibits149: GlaxoSmithKline Plc - Segment focus
• Exhibits150: Johnson and Johnson - Overview
• Exhibits151: Johnson and Johnson - Business segments
• Exhibits152: Johnson and Johnson - Key news
• Exhibits153: Johnson and Johnson - Key offerings
• Exhibits154: Johnson and Johnson - Segment focus
• Exhibits155: Novavax Inc. - Overview
• Exhibits156: Novavax Inc. - Product / Service
• Exhibits157: Novavax Inc. - Key offerings
• Exhibits158: Sanofi SA - Overview
• Exhibits159: Sanofi SA - Business segments
• Exhibits160: Sanofi SA - Key news
• Exhibits161: Sanofi SA - Key offerings
• Exhibits162: Sanofi SA - Segment focus
• Exhibits163: SIGA Technologies Inc. - Overview
• Exhibits164: SIGA Technologies Inc. - Product / Service
• Exhibits165: SIGA Technologies Inc. - Key offerings
• Exhibits166: Soligenix Inc. - Overview
• Exhibits167: Soligenix Inc. - Business segments
• Exhibits168: Soligenix Inc. - Key offerings
• Exhibits169: Soligenix Inc. - Segment focus
• Exhibits170: Tonix Pharmaceuticals Holding Corp. - Overview
• Exhibits171: Tonix Pharmaceuticals Holding Corp. - Product / Service
• Exhibits172: Tonix Pharmaceuticals Holding Corp. - Key offerings
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Information sources
• Exhibits179: List of abbreviations